These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
68 related articles for article (PubMed ID: 548990)
41. The determination of whole blood magnesium concentration in uremics on chronic dialysis. Gonella M; Buzzigoli G; Bencivelli W; Bartolini V; Betti G Nephron; 1981; 28(2):88-9. PubMed ID: 7290276 [TBL] [Abstract][Full Text] [Related]
42. In vitro inhibition of protein synthesis by dialysates of plasma from uraemic patients. Delaporte C; Gros F Eur J Clin Invest; 1981 Apr; 11(2 Suppl 1):139-43. PubMed ID: 6785098 [TBL] [Abstract][Full Text] [Related]
43. [Effect of hormones on the oxidative cycle of glucose-6-phosphate of erythrocytes]. SONKA J; DUBOVSKY J; PALEK J; SCHREIBER V Ann Endocrinol (Paris); 1957; 18(6):934-41. PubMed ID: 13521416 [No Abstract] [Full Text] [Related]
44. Agglutination of erythrocytes containing sulphaemoglobin; further evidence of specific aggregation. McKERNS KW; DENSTEDT OF Can J Res; 1949 Jun; Sect E 27(3):164-70. PubMed ID: 18151261 [No Abstract] [Full Text] [Related]
45. The disappearance of sulphaemoglobin from circulating blood in relation to red cell destruction. JOPE EM Proc R Soc Med; 1946 Sep; 39(11):760-2. PubMed ID: 21001870 [No Abstract] [Full Text] [Related]
46. THE BURR cell in uraemia. Br Med J; 1958 Feb; 1(5067):390-1. PubMed ID: 13499965 [No Abstract] [Full Text] [Related]
47. High circulating concentrations of glucagon in non-anaemic uraemic patients. McEvoy J; McCarroll AM Br Med J; 1978 Jul; 2(6129):17-8. PubMed ID: 678785 [No Abstract] [Full Text] [Related]
48. [Sulfhemoglobin]. Ohba Y Nihon Rinsho; 1995 Mar; 53 Su Pt 2():183-5. PubMed ID: 8753212 [No Abstract] [Full Text] [Related]
51. Red Blood Cell Dysfunction in Critical Illness. Rogers S; Doctor A Crit Care Clin; 2020 Apr; 36(2):267-292. PubMed ID: 32172813 [TBL] [Abstract][Full Text] [Related]
52. Shortened red blood cell survival in uremic patients: beneficial and deleterious effects of dialysis. Jacob HS; Eaton JW; Yawata Y Kidney Int Suppl; 1975 Jan; (2):139-43. PubMed ID: 1099299 [No Abstract] [Full Text] [Related]
53. Plasma inhibitors of the erythrocyte hexose monophosphate shunt in uraemia. Zingraff J; Kamoun P; Lebreton P; Drüeke T; Man NK; Jungers P Proc Eur Dial Transplant Assoc; 1979; 16():475-80. PubMed ID: 548990 [TBL] [Abstract][Full Text] [Related]
54. Ascorbate-cyanide test on red blood cells in uremia: effect of guanidinopropionic acid. Kamoun PP; Zingraff JJ; Turlin G; Lebreton P Nephron; 1981; 28(1):26-9. PubMed ID: 7266724 [TBL] [Abstract][Full Text] [Related]
55. The anemia of renal failure: the role of the hexose monophosphate shunt. Tet-Ken-Voo R Can J Med Technol; 1973 Oct; 35(5):14 passim. PubMed ID: 4756807 [No Abstract] [Full Text] [Related]
56. Improvement of insulin binding to erythrocyte insulin receptors in uraemia by haemodialysis. Milutinović S; Breyer D; Janković M; Stefović A; Molnar V; Mrzljak V; Rocić B Proc Eur Dial Transplant Assoc; 1983; 19():763-8. PubMed ID: 6348765 [TBL] [Abstract][Full Text] [Related]